Australian Rotavirus Surveillance Program, Annual report, 2006–07

Authors

  • Carl D Kirkwood National Rotavirus Reference Centre, Murdoch Childrens Research Institute, Royal Children’s Hospital, Parkville, Victoria
  • David Cannan National Rotavirus Reference Centre, Murdoch Childrens Research Institute, Royal Children’s Hospital, Parkville, Victoria
  • Nada Bogdanovic-Sakran National Rotavirus Reference Centre, Murdoch Childrens Research Institute, Royal Children’s Hospital, Parkville, Victoria
  • Ruth F Bishop National Rotavirus Reference Centre, Murdoch Childrens Research Institute, Royal Children’s Hospital, Parkville, Victoria
  • Graeme L Barnes National Rotavirus Reference Centre, Murdoch Childrens Research Institute, Royal Children’s Hospital, Parkville, Victoria
  • National Rotavirus Surveillance Group

DOI:

https://doi.org/10.33321/cdi.2007.31.39

Keywords:

rotavirus, disease surveillance, epidemiology

Abstract

The National Rotavirus Reference Centre, together with collaborating laboratories Australia-wide, conducts a laboratory based rotavirus surveillance program. This report describes the serotypes of rotavirus strains responsible for the hospitalisation of children with acute gastroenteritis during the period 1 July 2006 to 30 June 2007. One thousand and two faecal samples from across Australia were examined using a combined approach of monoclonal antibody immunoassays, reverse transcription-polymerase chain reaction and polyacrylamide gel analysis. Serotype G1 was the dominant serotype nationally, representing 36.7% of all strains, followed by serotype G9 (31.1%), and serotype G3 (23.3%). Serotype G2 represented less than 5% of strains, while no serotype G4 strains were identified. All G1, G3 and G9 strains assayed for P genotype contained the P[8] genotype, bar one G1 strain, which possessed a P[6]. Uncommon rotavirus genotypes, G8 (n=1) and G12 (n=2) were identified in children with acute gastroenteritis during this study period. Commun Dis Intell 2007;31:375–379.

Downloads

Download data is not yet available.

References

Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9:565–572.

Carlin JB, Chondros P, Masendycz P, Bugg H, Bishop RF, Barnes GL. Rotavirus infection and rates of hospitalisation for acute gastroenteritis in young children in Australia, 1993–1996. Med J Aust 1998;169:252–256.

Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23–33.

Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11–22.

Kirkwood CD, Bogdanovic-Sakran N, Clark R, Bishop RF, Barnes GL. Report of the Australian Rotavirus Surveillance Program, 2002/2003. Commun Dis Intell 2003;27:492–495.

Kirkwood C, Bogdanovic-Sakran N, Bishop R, Barnes G. Report of the Australian Rotavirus Surveillance Program, 2003/2004. Commun Dis Intell 2004;28:481–485.

Coulson B, Unicomb Pitson G, Bishop R. Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping human rotaviruses. J Clin Microbiol 1987;25:509–515.

Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B, Fang ZY. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990;28:276–282.

Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992;30:1365–1373.

Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005;15:29–56.

Gentsch J, Laird A, Biefelt B, Griffin D, Banyau K, Ramachandran M, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005;192:S146–S159.

Kirkwood CD, Bogdanovic-Sakran N, Cannan D, Bishop RF, Barnes GL. National Rotavirus Surveillance Program, annual report: 2004–05. Commun Dis Intell 2006;30:120–123.

Kirkwood CD, Cannan D, Bogdanovic-Sakran N, Bishop RF, Barnes GL; National Rotavirus Surveillance Group. National Rotavirus Surveillance Program annual report, 2005–06. Commun Dis Intell 2006;30:434–438.

Kirkwood C, Bogdanovic-Sakran N, Barnes G, Bishop R. Rotavirus serotype G9P[8] and acute gastroenteritis outbreak in children, Northern Australia. Emerg Infect Dis 2004;10:1593–1600.

Kirkwood C, Bogdanovic-Sakran N, Palombo E, Masendycz P, Bugg H, Barnes G, Bishop R. Genetic and antigenic characterization of rotavirus serotype G9 strains isolated in Australia between 1997 and 2001. J Clin Microbiol 2003;41:3649–3654.

Samajdar S, Varghese V, Barman P, Ghosh S, Mitra U, Dutta P, et al. Changing pattern of human group A rotaviruses: emergence of G12 as an important pathogen among children in eastern India. J Clin Virol 2006;36:183–188.

Rahman M, Matthijnssens J, Yang X, Delbeke T, Arijis I, Taniguchi K, et al. Evolutionary history and global spread of the emerging G12 human rotaviruses. J Virol 2007;81:2382–2390.

Cooney MA, Gorrell RJ, Palombo EA. Characterisation and phylogenetic analysis of the VP7 proteins of serotype G6 and G8 human rotaviruses. J Med Microbiol 2001;50:462–467.

Downloads

Published

01/12/07

How to Cite

Kirkwood, Carl D, David Cannan, Nada Bogdanovic-Sakran, Ruth F Bishop, Graeme L Barnes, and National Rotavirus Surveillance Group. 2007. “Australian Rotavirus Surveillance Program, Annual Report, 2006–07”. Communicable Diseases Intelligence 31 (December):375-79. https://doi.org/10.33321/cdi.2007.31.39.